Advertisement
Pharmacy Today, February 2013
February 01, 2013
February 2013 • Volume 19, Number 2
Features
32 Focus on prostate cancer: Recent therapies improve morbidity and mortality
34 TKIs hit the market: Bosulif, Iclusig, and Cometriq approved to treat cancers
36 Pasireotide: Somatostatin analog is orphan drug for Cushing disease
38 Raxibacumab: New monoclonal antibody for inhalational anthrax
40 MTM profile: Kumbera and Halterman and creating a new business model at OutcomesMTM
44 Project IMPACT: Expanding diabetes care at Price Chopper Pharmacy and Ball's Food Stores
46 Building pharmacy capacity for MTM: Article points to three areas of research
48 Incentive grants: APhA Foundation program funds pharmacy-based projects
Policy and Advocacy
52 On the docket: Pharmacist responsibilities do not extend to therapists
53 Hub on policy and advocacy: Provider status; Walgreens forms ACOs
58 Petition: Student pharmacist opens White House provider status petition
59 Compounding: Massachusetts governor proposes compounding bill
60 PCORI: Iowa project advances dementia care for rural, Hispanic populations
Departments
6 Today's perspective: APhA2013: Your voice, your profession, our legacy
12 Pharmacists in Action: Provider status, 'Minute with' Nelson Kardos, 340B at APhA2013
22 Product showcase: New approvals, indications, and formulations
24 OTCs today: Insomnia in children with autism spectrum disorder
25 Integrative medicine: Coenzyme Q10 and heart failure
26 Immunization update: Flu sweeps the nation
28 One to one: Counseling and mental health conditions
29 MTM pearls: Strategic planning to ensure success
30 Technology forum: Sharing data with HIT
76 Error alert: Student pharmacists help find errors
Health-System Edition
HSE 2 Insomnia: Entitlement and employability among future pharmacists: Part 1
HSE 4 Many faces of MTM: DePietro, nuclear pharmacy essential to Mass General patient care
HSE 7 Compounding: The ties between compounding and drug shortages
Related Content
